Kovitz Investment Group Partners’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Sell
135,017
-12,121
-8% -$110K 0.04% 252
2026
Q1
$1.04M Sell
147,138
-10,720
-7% -$75.7K 0.02% 318
2025
Q4
$781K Sell
157,858
-45,373
-22% -$191K 0.02% 347
2025
Q3
$917K Sell
203,231
-1,603
-0.8% -$5.46K ﹤0.01% 864
2025
Q2
$639K Sell
204,834
-21,486
-9% -$60.5K ﹤0.01% 907
2025
Q1
$568K Buy
226,320
+194,055
+601% +$608K ﹤0.01% 873
2024
Q4
$100K Hold
32,265
﹤0.01% 1201
2024
Q3
$76.8K Hold
32,265
﹤0.01% 991
2024
Q2
$81.6K Buy
32,265
+2,549
+9% +$6.49K ﹤0.01% 811
2024
Q1
$87.7K Buy
+29,716
New +$91.3K ﹤0.01% 652

Other funds holding DRTS

Kovitz Investment Group Partners's DRTS Position: Q2 2026 in Review

Kovitz Investment Group Partners reduced its Alpha Tau Medical (DRTS) stake by 8.2% in Q2 2026, selling an estimated $110K and leaving 135,017 shares worth $1.7M. The position accounts for 0.04% of the portfolio, ranked #252.

Kovitz Investment Group Partners first reported a position in DRTS in Q1 2024 and has held it in 10 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Kovitz Investment Group Partners held 135,017 shares of Alpha Tau Medical worth $1.7M as of Q2 2026.
  • Kovitz Investment Group Partners sold 12,121 Alpha Tau Medical shares in Q2 2026, an estimated $110K.
  • Alpha Tau Medical made up 0.04% of Kovitz Investment Group Partners's portfolio in Q2 2026, its #252 holding.
  • Kovitz Investment Group Partners first reported a position in Alpha Tau Medical in Q1 2024 and has held it in 10 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q2 2026, filed 12 Aug 2026.